Journey Colab Email Format
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
Journey Colab is a San Francisco–based pharmaceutical manufacturing company with a small team of 2 to 10 employees. It focuses on psychedelics to address addiction, seeking to combine neuroplasticity-promoting therapeutics with psychotherapy and community support to create a new model of addiction care and to improve equitable access to care. The lead compound is synthetic mescaline hydrochloride being developed for alcohol use disorder. The company has pursued leadership appointments and partnerships, including appointing Joel A. Posener, MD as Chief Medical Officer in 2022 and collaborating with All Points North to advance late-stage trials and administration models for psychedelic therapies. Journey Colab is privately held and was initially funded by Sam Altman and Apollo Projects, with a Series A financing in 2021.